about
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma.Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients.Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infectionAntibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodiesReduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infectionHuman cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.Monitoring human cytomegalovirus infection in transplant recipients.Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.Role of human cytomegalovirus (HCMV)-specific antibody in HCMV-infected pregnant women.Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development.Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.Analytic Vaccinology: Antibody-Driven Design of a Human Cytomegalovirus Subunit Vaccine.Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.Sustained impairment of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cell response is responsible for recurrent episodes of disseminated HCMV infection in a D+R- hand transplant recipient.Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.New advances in CMV and immunosenescence.Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia.Heart rate and cardiac allograft vasculopathy in heart transplant recipients.In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients.Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells.Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy.Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission.
P50
Q24813114-F42EC8D4-B3F5-41B3-95EA-CCF28C80F93DQ33999790-F70990FA-90FB-4A01-B7C3-003C7FDE3CAAQ34358755-35C75632-1FE3-4E8B-886B-0D382B1DB45CQ34652466-8E4863A3-C0B8-4193-A7EF-0E8F8F149036Q34753135-017FA1A2-09EB-49C1-8A22-0375A1BD7060Q35196400-343AA886-5646-4BAC-B1FE-B5186B11589AQ35233773-E327C9E2-B023-449B-8543-91D6484D19ABQ37032510-FDC478DA-951A-46C4-A97B-A29B8E14E65AQ37059970-52113DC9-7CD1-4D1E-9E22-10591818DA72Q37073289-689455AA-5678-48F9-95D4-8D56FE8E1C3AQ37127717-708C2A7C-8250-4B65-B25A-30BFA7CAF830Q38202773-369E7BD4-B84D-4E43-BAAE-A0502FA47061Q38835171-876379B4-2AE0-4E1D-A67F-F639BA0EC386Q39020960-04512F31-5524-4CEF-BD60-012D3D842378Q39051240-A5754005-D621-456D-ADDD-5BAD785BBFE3Q39591457-0C02FA0E-6442-4DFE-BD91-C46B5F9FB50BQ40082753-6481CF34-78D8-4DE4-91E8-06EC21DF75B3Q40507092-F6140233-AAD2-425B-8EE0-D1FB527B16F4Q40510516-63F5AB51-9D58-4737-B695-4BE1465EAC1AQ40699620-2A61F46A-7AFE-4BF5-8833-FDA4411982BCQ40715812-38DB0BC0-9E17-40AA-B816-E626ECC40D33Q41060153-269AB892-AAB4-4C84-A9A6-5F1ACCDECF96Q41457523-2EDB1253-DC37-4175-ACC5-F7B2D9360D52Q41700775-FF3C0FB6-6826-447B-949F-FAB1A16EBD41Q41735217-BA9B691C-BD0A-4319-AE64-31A2E94F09AAQ41882832-83BA19BF-A166-4AC5-BC7C-BB05480C7FB6Q42253427-06E5F565-99FA-4F7D-AFC7-AE55C7EB37A8Q42652611-3824D5DA-C66A-4C57-BF38-B6026884CD6CQ43729462-D6345D0F-7155-4C22-8CBB-D223179D1ABDQ44317793-9E9EF6D9-2E4F-47D1-ACD0-CDC0C243E76CQ44618517-F8FBC88C-D7CF-44A2-8DC5-FE80F8CD87FBQ44647294-B2BD52E7-D2C0-4A52-8055-468BACC6F7E9Q44669550-E1B42A10-19F0-4359-9797-0D41D637E8D7Q44739030-F75F7C2F-D929-44F8-961F-3A72367B6F05Q45000960-0D41F15D-2B4B-4796-ACA2-54051F536B08Q45355919-AB48BCA9-A976-450C-A369-984C203DA121Q45364081-F2BEB233-147E-4975-8A93-F320BC7CF8EAQ45406643-21CB5562-C895-4872-919E-D2C5507B246AQ45408880-E4654D68-2FE2-466D-ACAE-C9F68243752FQ45851061-011B500E-AD96-4D29-8C07-0A82B4748A4B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniele Lilleri
@ast
Daniele Lilleri
@en
Daniele Lilleri
@es
Daniele Lilleri
@fr
Daniele Lilleri
@nl
Daniele Lilleri
@sl
type
label
Daniele Lilleri
@ast
Daniele Lilleri
@en
Daniele Lilleri
@es
Daniele Lilleri
@fr
Daniele Lilleri
@nl
Daniele Lilleri
@sl
prefLabel
Daniele Lilleri
@ast
Daniele Lilleri
@en
Daniele Lilleri
@es
Daniele Lilleri
@fr
Daniele Lilleri
@nl
Daniele Lilleri
@sl
P106
P1153
6603247619
P21
P31
P496
0000-0001-7747-7622